| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Neuropathy, Ischemic | 13 | 2023 | 72 | 3.740 |
Why?
|
| Visual Prosthesis | 9 | 2021 | 52 | 3.240 |
Why?
|
| Electric Stimulation | 24 | 2011 | 1761 | 3.130 |
Why?
|
| Retinal Ganglion Cells | 22 | 2017 | 760 | 2.740 |
Why?
|
| Retina | 27 | 2020 | 2627 | 2.530 |
Why?
|
| Blindness | 21 | 2020 | 598 | 2.430 |
Why?
|
| Electrodes, Implanted | 15 | 2020 | 783 | 2.320 |
Why?
|
| Giant Cell Arteritis | 7 | 2021 | 257 | 2.280 |
Why?
|
| Retinal Artery Occlusion | 7 | 2021 | 66 | 2.230 |
Why?
|
| Optic Neuritis | 12 | 2017 | 168 | 2.190 |
Why?
|
| Vision Disorders | 21 | 2020 | 1037 | 1.600 |
Why?
|
| Microelectrodes | 14 | 2020 | 301 | 1.300 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 2 | 2017 | 7 | 1.280 |
Why?
|
| Retinal Diseases | 11 | 2021 | 670 | 1.280 |
Why?
|
| Optic Disk | 14 | 2020 | 392 | 1.190 |
Why?
|
| Action Potentials | 12 | 2011 | 1781 | 1.170 |
Why?
|
| Intracranial Hypertension | 4 | 2021 | 181 | 1.140 |
Why?
|
| Retinitis Pigmentosa | 5 | 2012 | 367 | 1.080 |
Why?
|
| Prosthesis Implantation | 8 | 2011 | 659 | 1.070 |
Why?
|
| Temporal Arteries | 5 | 2015 | 132 | 1.020 |
Why?
|
| Ophthalmic Artery | 3 | 2021 | 65 | 1.020 |
Why?
|
| Retinal Artery | 3 | 2021 | 114 | 1.000 |
Why?
|
| Vision, Ocular | 10 | 2021 | 465 | 0.990 |
Why?
|
| Tomography, Optical Coherence | 8 | 2020 | 2485 | 0.960 |
Why?
|
| Sensory Thresholds | 7 | 2009 | 402 | 0.960 |
Why?
|
| Ocular Motility Disorders | 4 | 2017 | 138 | 0.950 |
Why?
|
| Orbital Neoplasms | 4 | 2022 | 238 | 0.910 |
Why?
|
| Visual Fields | 19 | 2018 | 1027 | 0.900 |
Why?
|
| Evoked Potentials, Visual | 9 | 2009 | 425 | 0.830 |
Why?
|
| Electric Stimulation Therapy | 6 | 2011 | 617 | 0.830 |
Why?
|
| Eye Neoplasms | 2 | 2022 | 312 | 0.820 |
Why?
|
| Adnexal Diseases | 1 | 2022 | 104 | 0.810 |
Why?
|
| Optic Nerve Diseases | 15 | 2017 | 319 | 0.800 |
Why?
|
| Eye, Artificial | 2 | 2012 | 22 | 0.800 |
Why?
|
| Sex Reassignment Procedures | 1 | 2021 | 56 | 0.790 |
Why?
|
| Retinal Vessels | 5 | 2021 | 763 | 0.760 |
Why?
|
| Scotoma | 4 | 2017 | 130 | 0.740 |
Why?
|
| Vision, Monocular | 2 | 2017 | 72 | 0.740 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 210 | 0.710 |
Why?
|
| Electroretinography | 15 | 2009 | 544 | 0.710 |
Why?
|
| Telemetry | 2 | 2011 | 195 | 0.710 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2017 | 46 | 0.700 |
Why?
|
| Intracranial Pressure | 1 | 2021 | 325 | 0.700 |
Why?
|
| Diplopia | 4 | 2013 | 180 | 0.690 |
Why?
|
| Visual Acuity | 21 | 2021 | 2488 | 0.680 |
Why?
|
| Pseudotumor Cerebri | 2 | 2017 | 86 | 0.680 |
Why?
|
| Prosthesis Design | 7 | 2012 | 2107 | 0.670 |
Why?
|
| Coated Materials, Biocompatible | 4 | 2009 | 319 | 0.670 |
Why?
|
| Isaacs Syndrome | 1 | 2017 | 6 | 0.660 |
Why?
|
| Embolism | 1 | 2021 | 381 | 0.650 |
Why?
|
| Prostheses and Implants | 7 | 2009 | 1345 | 0.650 |
Why?
|
| Exotropia | 1 | 2017 | 42 | 0.640 |
Why?
|
| Abducens Nerve Diseases | 1 | 2017 | 38 | 0.630 |
Why?
|
| Eye Diseases | 7 | 2004 | 654 | 0.630 |
Why?
|
| Hypotension | 1 | 2023 | 828 | 0.630 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 688 | 0.620 |
Why?
|
| GTP Phosphohydrolases | 2 | 2017 | 509 | 0.600 |
Why?
|
| Videotape Recording | 1 | 2017 | 353 | 0.570 |
Why?
|
| Papilledema | 5 | 2010 | 113 | 0.560 |
Why?
|
| Rabbits | 18 | 2011 | 5061 | 0.550 |
Why?
|
| Optic Nerve | 9 | 2002 | 549 | 0.510 |
Why?
|
| Choroidal Neovascularization | 1 | 2017 | 346 | 0.490 |
Why?
|
| Vision Tests | 4 | 2010 | 156 | 0.490 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2019 | 660 | 0.480 |
Why?
|
| Pituitary Gland | 1 | 2016 | 664 | 0.480 |
Why?
|
| Iridium | 2 | 2011 | 30 | 0.480 |
Why?
|
| Horner Syndrome | 1 | 2013 | 33 | 0.470 |
Why?
|
| Oculomotor Muscles | 4 | 2010 | 329 | 0.450 |
Why?
|
| Subclavian Artery | 1 | 2013 | 130 | 0.450 |
Why?
|
| Differential Threshold | 2 | 2011 | 83 | 0.440 |
Why?
|
| Blepharoptosis | 1 | 2013 | 137 | 0.430 |
Why?
|
| Psychological Tests | 1 | 2014 | 643 | 0.430 |
Why?
|
| Internationality | 2 | 2016 | 997 | 0.430 |
Why?
|
| Headache | 3 | 2018 | 1152 | 0.420 |
Why?
|
| Fluorescein Angiography | 7 | 2017 | 890 | 0.420 |
Why?
|
| Visual Perception | 8 | 2016 | 1398 | 0.420 |
Why?
|
| GABA Antagonists | 1 | 2011 | 132 | 0.410 |
Why?
|
| Nervous System Diseases | 5 | 2004 | 1648 | 0.410 |
Why?
|
| Ciliary Arteries | 2 | 2021 | 18 | 0.410 |
Why?
|
| Swine, Miniature | 4 | 2020 | 955 | 0.400 |
Why?
|
| Biomedical Engineering | 2 | 2009 | 292 | 0.400 |
Why?
|
| Orbital Myositis | 2 | 2020 | 20 | 0.380 |
Why?
|
| Aneurysm | 1 | 2013 | 320 | 0.380 |
Why?
|
| Nystagmus, Pathologic | 1 | 2010 | 88 | 0.380 |
Why?
|
| Choroid | 3 | 1999 | 311 | 0.380 |
Why?
|
| Cluster Headache | 2 | 2020 | 54 | 0.370 |
Why?
|
| Advisory Committees | 1 | 2014 | 759 | 0.370 |
Why?
|
| Awards and Prizes | 1 | 2013 | 346 | 0.360 |
Why?
|
| Materials Testing | 3 | 2009 | 864 | 0.360 |
Why?
|
| Implants, Experimental | 1 | 2009 | 105 | 0.360 |
Why?
|
| Microtechnology | 1 | 2009 | 73 | 0.350 |
Why?
|
| Humans | 134 | 2023 | 715636 | 0.350 |
Why?
|
| Eye Movements | 3 | 2010 | 484 | 0.350 |
Why?
|
| Arteritis | 3 | 2019 | 139 | 0.350 |
Why?
|
| Ophthalmology | 2 | 2013 | 488 | 0.340 |
Why?
|
| Neuromuscular Agents | 1 | 2010 | 138 | 0.340 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2009 | 126 | 0.340 |
Why?
|
| Photic Stimulation | 7 | 2009 | 2014 | 0.330 |
Why?
|
| Glucocorticoids | 7 | 2018 | 2104 | 0.330 |
Why?
|
| Neuromyelitis Optica | 3 | 2017 | 208 | 0.320 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2010 | 199 | 0.320 |
Why?
|
| Ischemia | 4 | 2021 | 1903 | 0.300 |
Why?
|
| Sodium Channels | 1 | 2009 | 359 | 0.300 |
Why?
|
| Visual Pathways | 5 | 2009 | 586 | 0.300 |
Why?
|
| Axons | 5 | 2012 | 1729 | 0.290 |
Why?
|
| Retinal Vein Occlusion | 2 | 1999 | 123 | 0.290 |
Why?
|
| Neurology | 1 | 2013 | 746 | 0.280 |
Why?
|
| Swine | 5 | 2020 | 5800 | 0.280 |
Why?
|
| Electrodes | 4 | 2011 | 588 | 0.280 |
Why?
|
| Strabismus | 3 | 2010 | 254 | 0.280 |
Why?
|
| Animals | 37 | 2021 | 169277 | 0.270 |
Why?
|
| Nerve Net | 2 | 2008 | 2138 | 0.270 |
Why?
|
| Multiple Sclerosis | 4 | 2015 | 3002 | 0.270 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 597 | 0.260 |
Why?
|
| Paraneoplastic Syndromes | 3 | 1997 | 155 | 0.260 |
Why?
|
| Retinaldehyde | 1 | 2003 | 27 | 0.260 |
Why?
|
| Biological Clocks | 1 | 2007 | 327 | 0.260 |
Why?
|
| Retinal Degeneration | 2 | 2008 | 411 | 0.250 |
Why?
|
| Device Removal | 1 | 2009 | 650 | 0.250 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 587 | 0.250 |
Why?
|
| Reaction Time | 3 | 2006 | 2110 | 0.250 |
Why?
|
| Diagnosis, Differential | 14 | 2020 | 13215 | 0.240 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 57 | 0.240 |
Why?
|
| Chronotherapy | 1 | 2023 | 12 | 0.240 |
Why?
|
| Visual Field Tests | 5 | 2017 | 374 | 0.240 |
Why?
|
| Semiconductors | 1 | 2004 | 101 | 0.240 |
Why?
|
| Biocompatible Materials | 3 | 2007 | 1701 | 0.240 |
Why?
|
| Mitochondria | 1 | 2016 | 3614 | 0.230 |
Why?
|
| Sneezing | 1 | 2002 | 18 | 0.230 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 16 | 0.230 |
Why?
|
| Pupil Disorders | 1 | 2002 | 26 | 0.220 |
Why?
|
| Spinal Puncture | 3 | 2018 | 282 | 0.220 |
Why?
|
| Membrane Potentials | 2 | 2005 | 1167 | 0.220 |
Why?
|
| Recovery of Function | 3 | 2018 | 2920 | 0.220 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2838 | 0.220 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2021 | 1455 | 0.220 |
Why?
|
| Acetazolamide | 2 | 2017 | 96 | 0.220 |
Why?
|
| Models, Neurological | 3 | 2010 | 1780 | 0.220 |
Why?
|
| Fundus Oculi | 8 | 2017 | 458 | 0.220 |
Why?
|
| Occipital Lobe | 1 | 2004 | 381 | 0.220 |
Why?
|
| Carotid Artery, Internal | 3 | 2021 | 459 | 0.210 |
Why?
|
| Tissue Engineering | 2 | 2009 | 1828 | 0.210 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 238 | 0.210 |
Why?
|
| Optic Nerve Neoplasms | 3 | 2009 | 50 | 0.200 |
Why?
|
| Female | 66 | 2022 | 377052 | 0.200 |
Why?
|
| Nervous System Neoplasms | 1 | 2001 | 94 | 0.200 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 1192 | 0.190 |
Why?
|
| Intraocular Pressure | 4 | 2021 | 1165 | 0.190 |
Why?
|
| Intracranial Aneurysm | 2 | 2004 | 1305 | 0.190 |
Why?
|
| Biopsy | 5 | 2016 | 6732 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2007 | 1292 | 0.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2015 | 2688 | 0.190 |
Why?
|
| Aged | 43 | 2021 | 162383 | 0.180 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2000 | 335 | 0.180 |
Why?
|
| Optic Nerve Injuries | 3 | 1999 | 153 | 0.180 |
Why?
|
| Ocular Hypertension | 1 | 2020 | 189 | 0.180 |
Why?
|
| Adult | 53 | 2021 | 212228 | 0.170 |
Why?
|
| Light | 3 | 2007 | 1434 | 0.170 |
Why?
|
| Optic Disk Drusen | 1 | 2017 | 36 | 0.160 |
Why?
|
| Subretinal Fluid | 1 | 2017 | 22 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 1743 | 0.160 |
Why?
|
| Male | 60 | 2021 | 350156 | 0.160 |
Why?
|
| Reading | 1 | 2021 | 549 | 0.150 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 94 | 0.150 |
Why?
|
| PC12 Cells | 2 | 2007 | 352 | 0.150 |
Why?
|
| Hemianopsia | 1 | 2018 | 125 | 0.150 |
Why?
|
| Vision, Low | 2 | 2008 | 159 | 0.150 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2019 | 364 | 0.150 |
Why?
|
| Neural Prostheses | 1 | 2016 | 20 | 0.150 |
Why?
|
| MELAS Syndrome | 1 | 2016 | 52 | 0.150 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2016 | 98 | 0.150 |
Why?
|
| Neurosyphilis | 1 | 2016 | 26 | 0.140 |
Why?
|
| Glaucoma | 2 | 2021 | 995 | 0.140 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 317 | 0.140 |
Why?
|
| Neurites | 2 | 2009 | 389 | 0.140 |
Why?
|
| Visual Cortex | 3 | 2006 | 1140 | 0.140 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2016 | 49 | 0.140 |
Why?
|
| Retrospective Studies | 14 | 2022 | 72439 | 0.140 |
Why?
|
| Susac Syndrome | 1 | 2015 | 23 | 0.140 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 148 | 0.140 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 1995 | 26 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 3413 | 0.140 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 863 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2018 | 34428 | 0.130 |
Why?
|
| Perceptual Disorders | 1 | 2016 | 195 | 0.130 |
Why?
|
| Middle Aged | 47 | 2021 | 214618 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2008 | 458 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2020 | 1153 | 0.130 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 483 | 0.130 |
Why?
|
| Neurons | 3 | 2009 | 9377 | 0.130 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1995 | 112 | 0.130 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 572 | 0.120 |
Why?
|
| Acute Disease | 5 | 2017 | 7137 | 0.120 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 795 | 0.120 |
Why?
|
| Infarction | 1 | 1994 | 224 | 0.120 |
Why?
|
| Injections, Intramuscular | 2 | 2010 | 562 | 0.120 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2055 | 0.110 |
Why?
|
| Angiography | 1 | 2018 | 1626 | 0.110 |
Why?
|
| Meningioma | 3 | 2009 | 1199 | 0.110 |
Why?
|
| Cerebrovascular Disorders | 3 | 2003 | 1505 | 0.110 |
Why?
|
| Meningeal Neoplasms | 3 | 2009 | 1215 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2017 | 1929 | 0.110 |
Why?
|
| Ophthalmoplegia | 2 | 2004 | 169 | 0.110 |
Why?
|
| Amblyopia | 1 | 1993 | 123 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2011 | 19905 | 0.110 |
Why?
|
| Electrophysiology | 4 | 2010 | 1316 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2012 | 457 | 0.100 |
Why?
|
| Melatonin | 3 | 2002 | 719 | 0.100 |
Why?
|
| Retinal Vasculitis | 1 | 2011 | 43 | 0.100 |
Why?
|
| New York | 1 | 2013 | 861 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1841 | 0.100 |
Why?
|
| Blood Flow Velocity | 3 | 2004 | 1438 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2016 | 774 | 0.100 |
Why?
|
| Ophthalmoscopes | 1 | 2010 | 25 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2015 | 664 | 0.100 |
Why?
|
| Equipment Design | 2 | 2009 | 3587 | 0.100 |
Why?
|
| Young Adult | 7 | 2021 | 56137 | 0.100 |
Why?
|
| Histocytochemistry | 1 | 2011 | 755 | 0.100 |
Why?
|
| Vitrectomy | 2 | 2004 | 361 | 0.100 |
Why?
|
| Retinal Neurons | 1 | 2010 | 71 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 2016 | 524 | 0.100 |
Why?
|
| Circadian Rhythm | 4 | 2007 | 2547 | 0.100 |
Why?
|
| Capillaries | 3 | 2020 | 777 | 0.090 |
Why?
|
| Electrochemistry | 1 | 2009 | 155 | 0.090 |
Why?
|
| Neurofibromatosis 1 | 1 | 1994 | 538 | 0.090 |
Why?
|
| Radioisotopes | 1 | 2010 | 502 | 0.090 |
Why?
|
| Ankyrins | 1 | 2009 | 123 | 0.090 |
Why?
|
| Ethambutol | 1 | 2008 | 61 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2097 | 0.090 |
Why?
|
| Telecommunications | 1 | 2009 | 83 | 0.090 |
Why?
|
| Polylysine | 1 | 2009 | 134 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 1995 | 888 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2406 | 0.080 |
Why?
|
| Eye Movement Measurements | 1 | 2008 | 33 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 1995 | 2023 | 0.080 |
Why?
|
| Artifacts | 2 | 2011 | 1912 | 0.080 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2007 | 31 | 0.080 |
Why?
|
| Boston | 2 | 2012 | 9374 | 0.080 |
Why?
|
| Reflex, Pupillary | 1 | 2007 | 60 | 0.080 |
Why?
|
| Aging | 6 | 2008 | 8352 | 0.080 |
Why?
|
| Conjunctiva | 1 | 2011 | 487 | 0.080 |
Why?
|
| Biophysics | 1 | 2009 | 392 | 0.080 |
Why?
|
| Rats | 3 | 2011 | 24802 | 0.080 |
Why?
|
| Laurence-Moon Syndrome | 1 | 1986 | 8 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2013 | 1565 | 0.080 |
Why?
|
| Mutation | 5 | 2017 | 29270 | 0.080 |
Why?
|
| Motion Perception | 2 | 2009 | 372 | 0.080 |
Why?
|
| Collagen | 2 | 2021 | 2664 | 0.080 |
Why?
|
| Visually Impaired Persons | 1 | 2007 | 78 | 0.080 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 1013 | 0.080 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2006 | 62 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2074 | 0.080 |
Why?
|
| Electromyography | 2 | 2010 | 1373 | 0.080 |
Why?
|
| Spasm | 1 | 1986 | 105 | 0.080 |
Why?
|
| Nerve Fibers | 2 | 2017 | 709 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 19528 | 0.070 |
Why?
|
| Lactates | 1 | 2007 | 405 | 0.070 |
Why?
|
| Anesthetics, Local | 2 | 2004 | 986 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2021 | 3312 | 0.070 |
Why?
|
| Optic Atrophy | 1 | 1986 | 66 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 969 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2023 | 51355 | 0.070 |
Why?
|
| Genetic Testing | 2 | 2017 | 3347 | 0.070 |
Why?
|
| Dysautonomia, Familial | 1 | 1986 | 83 | 0.070 |
Why?
|
| Eye Injuries | 1 | 2009 | 218 | 0.070 |
Why?
|
| Surface Properties | 1 | 2009 | 1177 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 156 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 235 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 3491 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2009 | 4903 | 0.070 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 564 | 0.070 |
Why?
|
| Blast Injuries | 1 | 2009 | 274 | 0.070 |
Why?
|
| Gadolinium | 1 | 2010 | 912 | 0.070 |
Why?
|
| Homeostasis | 1 | 2016 | 3330 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2013 | 2823 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 2114 | 0.070 |
Why?
|
| Lacrimal Apparatus | 1 | 1987 | 214 | 0.070 |
Why?
|
| Gold | 1 | 2009 | 471 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 992 | 0.070 |
Why?
|
| Radiography | 2 | 2012 | 6975 | 0.070 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2006 | 250 | 0.070 |
Why?
|
| Macular Degeneration | 1 | 2012 | 938 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2019 | 9028 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2005 | 426 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2006 | 293 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 253 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2015 | 4150 | 0.060 |
Why?
|
| Quality of Life | 3 | 2021 | 11719 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 511 | 0.060 |
Why?
|
| Blood Circulation | 1 | 2004 | 253 | 0.060 |
Why?
|
| Foreign-Body Reaction | 1 | 2004 | 160 | 0.060 |
Why?
|
| Awareness | 1 | 2007 | 600 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2840 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1282 | 0.060 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 66 | 0.060 |
Why?
|
| Calcium | 1 | 2016 | 5798 | 0.060 |
Why?
|
| Nervous System | 1 | 1986 | 565 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 792 | 0.060 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 255 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2184 | 0.060 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 4192 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21802 | 0.060 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2005 | 276 | 0.060 |
Why?
|
| Computer-Aided Design | 1 | 2004 | 271 | 0.060 |
Why?
|
| Hydrogels | 1 | 2007 | 629 | 0.060 |
Why?
|
| Orientation | 1 | 2004 | 325 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 914 | 0.050 |
Why?
|
| Injections, Epidural | 1 | 2003 | 191 | 0.050 |
Why?
|
| Microscopy, Polarization | 1 | 2021 | 90 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1987 | 476 | 0.050 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2003 | 102 | 0.050 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2002 | 65 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2320 | 0.050 |
Why?
|
| Phacoemulsification | 1 | 2003 | 139 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 1178 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 227 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 1000 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2020 | 47 | 0.050 |
Why?
|
| Polycythemia Vera | 1 | 2002 | 157 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1558 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2007 | 7982 | 0.050 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 58288 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 1296 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 5 | 2008 | 824 | 0.050 |
Why?
|
| Military Personnel | 1 | 2009 | 1062 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 22648 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 1987 | 1187 | 0.050 |
Why?
|
| Injections | 1 | 2003 | 867 | 0.050 |
Why?
|
| Alzheimer Disease | 4 | 1994 | 7261 | 0.050 |
Why?
|
| Apoptosis | 1 | 2016 | 9962 | 0.050 |
Why?
|
| Eye Burns | 1 | 2000 | 105 | 0.050 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 1409 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 8525 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 2104 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2010 | 6123 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 1986 | 1223 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2020 | 453 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2004 | 481 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 3 | 1999 | 769 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2002 | 457 | 0.040 |
Why?
|
| Artificial Organs | 1 | 2000 | 200 | 0.040 |
Why?
|
| Time Factors | 5 | 2006 | 40892 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1131 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 9815 | 0.040 |
Why?
|
| Adolescent | 14 | 2006 | 85064 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 856 | 0.040 |
Why?
|
| Albendazole | 1 | 1997 | 33 | 0.040 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 189 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2006 | 15101 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2009 | 1907 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39334 | 0.040 |
Why?
|
| Photography | 3 | 1997 | 528 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 23383 | 0.040 |
Why?
|
| Thailand | 1 | 2017 | 288 | 0.040 |
Why?
|
| Color Perception | 3 | 1994 | 220 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 389 | 0.040 |
Why?
|
| Spinal Fusion | 1 | 2006 | 1205 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2003 | 776 | 0.040 |
Why?
|
| Cryptococcosis | 1 | 1997 | 96 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 1683 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 70927 | 0.040 |
Why?
|
| Age Distribution | 1 | 2002 | 2942 | 0.040 |
Why?
|
| Optic Chiasm | 1 | 1996 | 96 | 0.040 |
Why?
|
| Smoking | 1 | 1993 | 8950 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 566 | 0.040 |
Why?
|
| Pregnancy | 2 | 2016 | 27366 | 0.040 |
Why?
|
| Syndrome | 3 | 2003 | 3193 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14887 | 0.030 |
Why?
|
| Glioma | 2 | 2001 | 3305 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3882 | 0.030 |
Why?
|
| Candidiasis | 1 | 1997 | 360 | 0.030 |
Why?
|
| Patient Selection | 1 | 2007 | 4294 | 0.030 |
Why?
|
| Brain | 4 | 2016 | 25191 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1379 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 1993 | 22 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2003 | 1530 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 1996 | 497 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 1754 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 1995 | 162 | 0.030 |
Why?
|
| Lasers | 2 | 2003 | 954 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1439 | 0.030 |
Why?
|
| Choroid Diseases | 1 | 1993 | 66 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4286 | 0.030 |
Why?
|
| Genital Diseases, Female | 1 | 1994 | 193 | 0.030 |
Why?
|
| Mice | 4 | 2009 | 80320 | 0.030 |
Why?
|
| Infant | 2 | 2008 | 34561 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3844 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 1997 | 699 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2008 | 15051 | 0.030 |
Why?
|
| Child | 5 | 2009 | 74418 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1268 | 0.030 |
Why?
|
| Eye | 1 | 2016 | 717 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2008 | 41184 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1878 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5032 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 1992 | 265 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2744 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1648 | 0.030 |
Why?
|
| Paclitaxel | 1 | 1998 | 1625 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4561 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 1994 | 647 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2016 | 987 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2002 | 11948 | 0.020 |
Why?
|
| Glaucoma, Neovascular | 1 | 1990 | 33 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1992 | 424 | 0.020 |
Why?
|
| Pelvis | 1 | 1994 | 697 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 15184 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3490 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1995 | 1368 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1992 | 917 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1832 | 0.020 |
Why?
|
| Age Factors | 4 | 2008 | 18774 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18185 | 0.020 |
Why?
|
| Cavernous Sinus | 1 | 1990 | 125 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2008 | 78 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1891 | 0.020 |
Why?
|
| Oxygen | 1 | 2020 | 4165 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2010 | 62037 | 0.020 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1987 | 22 | 0.020 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 1990 | 171 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6538 | 0.020 |
Why?
|
| Electrooculography | 1 | 2007 | 116 | 0.020 |
Why?
|
| Autoantigens | 1 | 1992 | 902 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2515 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5692 | 0.020 |
Why?
|
| Recurrence | 2 | 2015 | 8238 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 215 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1990 | 298 | 0.020 |
Why?
|